CYTOR and breast cancer: The data showed that the patients with relatively high LINC00152 expression (>median level) exhibited poorer prognosis than those with low LINC00152 expression (Figure 1E), suggesting that LINC00152 is overexpressed in breast cancer and is related with bad clinical outcome.